SEI INVESTMENTS CO

Position in FTRE — Fortrea Holdings Inc.

CIK 350894 OAKS, PA

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,200,907

+$971,174 QoQ

Shares Held

126,489

-3.1% QoQ

Ownership

0.133%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 334 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,273,690,748 across 210 Biotechnology names. FTRE ranks #52 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,200,907	126,489	-3.1%	Shares	Sole	2026-08-14
2026-03-31	$1,229,733	130,545	-3.7%	Shares	Sole	2026-05-13
2025-12-31	$2,339,634	135,631	+158.8%	Shares	Sole	2026-02-13
2025-09-30	$441,224	52,402	+385.7%	Shares	Sole	2025-11-13
2025-03-31	$81,456	10,789	-80.9%	Shares	Sole	2025-05-14
2024-12-31	$1,053,705	56,499	+45.4%	Shares	Sole	2025-02-11
2024-09-30	$777,220	38,861	-55.7%	Shares	Sole	2024-11-12
2024-06-30	$2,049,461	87,809	+11.3%	Shares	Sole	2024-08-13
2024-03-31	$3,165,961	78,873	+311.2%	Shares	Sole	2024-05-07
2023-12-31	$669,486	19,183	+33.2%	Shares	Sole	2024-02-14
2023-09-30	$411,667	14,399	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.